No-spa 40 mg 100 tablets — Made in France — Free Delivery

NO-SHPA® is an antispasmodic that eliminates spasm of smooth muscles and helps to eliminate pain caused by spasm.

Drotaverine, which is the active ingredient of the preparation, relieves spasm of smooth muscles of the gastrointestinal, biliary, urogenital and vascular systems. Strengthens blood circulation in tissues due to its ability to dilate blood vessels. Effectively acts on smooth muscle spasm of both nervous and muscular origin.

Antispasmodics work on smooth muscle and relieve pain caused by spasm. The antispasmodic drotaverine is used in gastroenterology, therapy, urology and gynecology in many countries of the world.

Gastroenterology. In this area, the preparation is prescribed for spastic pain accompanying the pathology of the biliary tract - gallstone disease, acute or chronic cholecystitis, cholangitis, etc.

Urology. Inflammatory processes in the urinary organs (cystitis, pyelitis) can also lead to spasms, so the use of drotaverine for these diseases is quite justified.

Tension headaches. Drotaverine can also be used to treat tension headaches, since muscle and vascular components are present in this case.

The favorable safety profile has been confirmed by numerous clinical studies.

Spasms of smooth muscles associated with diseases of the biliary tract: cholecystolithiasis, cholangiolithiasis, cholecystitis, pericholecystitis, cholangitis, papillitis.

Spasms of smooth muscles in diseases of the urinary tract: nephrolithiasis, urethrolithiasis, pyelitis, cystitis, tenesmus of the bladder.

As an adjunct treatment

with spasms of smooth muscles of the gastrointestinal tract: gastric ulcer and duodenal ulcer, gastritis, cardio- and / or pylorospasm, enteritis, colitis, spastic colitis with constipation and irritable bowel syndrome accompanied by flatulence;

tension headaches;

with gynecological diseases: dysmenorrhea.

Hypersensitivity to drotaverine or to any component of the preparation. Severe hepatic, renal, or heart failure (small cardiac output syndrome).

Adults: The usual average dose is 120-240 mg per day in 2-3 divided doses.

For children aged 6-12 years: the maximum daily dose is 80 mg (divided into 2 doses).

For children over 12 years of age: the maximum daily dose is 160 mg (divided into 2-4 doses).

Children

The use of the preparation is contraindicated in children under 6 years of age.

The use of drotaverine in children has not been evaluated in clinical studies.

Use during pregnancy or lactation

Pregnancy. The results of retrospective clinical studies showed that oral administration of the preparation did not cause any signs of any direct or indirect effect on pregnancy. However, it is necessary to prescribe the preparation to pregnant women with caution.

Lactation. Due to the lack of data during lactation, the use of the preparation  is not recommended.

Active substance: drotaverine; 1 tablet contains 40 mg drotaverine hydrochloride.

Excipients: magnesium stearate, talc, povidone, corn starch, lactose.

Keep out of the reach of children.

Store in original packaging at temperatures below 25 ° C.